Lipidomic profiling of extracellular vesicles derived from ...
Rapid Metabolomic and Lipidomic Analyses Utilizing Ion ... · Rapid Metabolomic and Lipidomic...
Transcript of Rapid Metabolomic and Lipidomic Analyses Utilizing Ion ... · Rapid Metabolomic and Lipidomic...
Rapid Metabolomic and Lipidomic Analyses Utilizing
Ion Mobility Spectrometry
Erin Shammel BakerXueyun Zheng, Noor A. Aly, Vanessa L. Paurus, Yuxuan Zhou, Berwyck L. J. Poad*, Stephen J. Blanksby*, Richard D. Smith Pacific Northwest National Laboratory*Queensland University of Technology, Brisbane Australia
Understanding health risks
Specific External Environment
General External Environment
Internal Environment
Health Risks
Understanding health risks
Specific External Environment
General External Environment
Internal Environment
Health Risks
1. Small molecules of interest occur from very low to high concentrations (fM-mM) so measurements with high dynamic range and sensitivity are essential
2. Biological changes are best understood when both endogenous metabolites and xenobiotics are analyzed
3. Untargeted measurements covering thousands of small molecules are desired to perform time course studies and analyze large cohorts
Main challenges with small molecule measurements
TestosteroneExact mass = 288.2089188
In the NIST database there are18 different options with exact mass = 288.2089188
4. Many small molecules have the same masses but a different chemical makeup so distinguishing them with MS-based approaches can be difficult or impossible
E
in out
Drift Time
Pulse of 2 ions with same m/z but different shape
Different conformers separate in time with peak heights representing the amount of each
Ion mobility concept
velocity is constant
v = K EK = ion mobility
Drift Cell
Ion mobility conceptLC (minutes) IMS (~60 ms) MS (~100 µs)
IMS MS
Elution Time Drift Time m/z
0 10 20 30 40 50 60
Elution Time (minutes)
Inte
nsity
20 30 40 50 60Drift Time (ms)
20 30 40 50 60Drift Time (ms)
20 30 40 50 60Drift Time (ms)
1100
100
m/z
1100
100
m/z
1100
100
m/z
Isomers difficult to separate with hydrophobic interaction liquid chromatography (HILIC)
D-Glucose-6-phosphate (G6P) α-D-Glucose-1-phosphate (G1P)
HH
D-Fructose-6-phosphate (F6P)
F6PG6P
F6P G6P G1P
G1P
Deprotonated form [M - H]- m/z = 259.02
Different ionization methods
ESI
DNA
Peptides
Drugs
Amino Acids
Sterols, Steroids
Fatty AcidsPAHs
HerbicidesPesticides
APPIAPCI
OH-PAHs
Organic Acids
Sugars
Lipids
PolarityNonpolar Very Polar
Mol
ecul
ar W
eigh
t
10
100
1,000
10,000
Proteins
NucleosidesNucleotides
ESI: Electrospray ionization
Antibiotics
Different ionization methods
ESI
DNA
Peptides
Drugs
Amino Acids
Sterols, Steroids
Fatty AcidsPAHs
HerbicidesPesticides
APPIAPCI
OH-PAHs
Organic Acids
Sugars
Lipids
PolarityNonpolar Very Polar
Mol
ecul
ar W
eigh
t
10
100
1,000
10,000
Proteins
NucleosidesNucleotides
ESI: Electrospray ionization
APCI: Atmospheric pressurechemical ionization
APPI: Atmospheric pressurephotoionization
Antibiotics
BAP: Benzo(a)Pyrene
BKF: Benzo(k)fluoranthene
Radical form [M]·+ m/z = 252.09
Isomeric xenobiotic separations
Pacific Northwest National Laboratory, RichlandAgilent Technologies, Inc., Santa Clara
Vanderbilt University, NashvilleBOKU – Univ. of Natural Resources and Life Sciences, Vienna
IMS collision cross section (CCS) precision
• Compare CCS accuracy across 4 international labs
• Analyze 80 molecules (metabolites, lipids, peptides and proteins) to determine CCS agreement
S. M. Stow, et al., Anal. Chem. 2017, 89, 9048-9055.
%RSD
Lipi
ds
[M-H
]-M
etab
olite
s [M
-H]-
Met
abol
ites
[M+H
]+&
[M+N
a]+
• Ran triplicate injections at all 4 labs
• Analyzed in positive and negative ion mode
• Mean %RSD of 0.24%
m/z
0.00% 0.10% 0.20% 0.30% 0.40% 0.50%C12:0C15:0C16:1C16:0C17:0C18:3C18:2C18:1C18:0C20:4C20:3C20:2C20:1
CreatL-aspartic acidL-glutamic acid
L-histidineL-phenylalanine
Uric AcidL-arginineL-tyrosineL-cystine
Pyr5PMTHF
CreatL-proline
L-threonineH-Cyst
Creat[M+Na]L-histidine
L-phenylalanineL-arginineL-tyrosine
GLC[M+Na]L-cystine
Pyr5PCyst[M+Na]
Pyr5P[M+Na]Cortisol
Cortisol[M+Na]MTHF 95% CIx
_Interlab comparison
Lowest detection at 10 pM for standards in water Linear concentration response
Limit of detection in water using IMS-MS
Lowest detection at 10 nMin human plasma
Lowest detection at 10 pM for standards in water Linear concentration response
Limit of detection in human plasma with IMS-MS
1. Inject Sample
SPE
Cart
ridge
2. Wash Cartridge
SPE
Cart
ridge
3. Reverse FlowSend to MS10 sec analyses
MS
SPE
Cart
ridge
Automated SPEsystem
12 24 36 48 60 72 84 96 108 120Time (s)
wash 6 sample injections/min
1
coun
ts (a
.u.)
2
3
Metabolites extracted from mouse plasma Metabolites extracted from human urine
328.5
328.0
327.5
327.0
18.0 18.5 19.0 19.5 20.0
Isomeric Separation: m/z=327.197
137.9
138.0
138.1
138.2
138.3
13.0 13.4 13.8 14.2
Same nominal mass: m/z=138.054, 138.129
330.0
330.3
330.2
330.1
330.4
19.5 20.0 20.5 21.0 21.5
330.5Isomeric Separation:
m/z=330.228
SPE-IMS-MS analyses of biological samples
~1400 features with S/N > 5 ~1000 features with S/N > 5
X. Zhang, et al., Clin. Mass Spectrom. 2016, 2, 1-10.
2.5
3
3.5
4
4.5
5
5.5
6
2.5 3 3.5 4 4.5 5 5.5
Log1
0 (In
tens
ity)
Log10 (Concentration in pM)
[Imazaquin+H]+
[Hexaconazole+H]+
[Thiabendazole+H]+
[Metribuzin+H]+
[Napropamide+H]+
[Flumeturon+H]+
[Isoxaben+H]+
[Oryzalin+H]+
[Fluroxypyr-1-methylheptyl ester+Na]+
[Resmethrin+Na]+
[Minocycline+H]+
[Fenamidone+H]+
[Fenamiphos+H]+
500 pM
100 nM
Calibration curve for xenobiotics in plasma
X. Zhang, et al., Clin. Mass Spectrom. 2016, 2, 1-10.
Small molecule pipeline
Extraction Instrumental Analysis Data Processing & Analysis
m/z
ID Mass Intensity
---- ---- ----
---- ---- ----
---- ---- ----
---- ---- ----
---- ---- ----
Methanol/Chloroform Extraction
(100 samples/day)
SPE-IMS-MS
(8200 samples/day)
Database Matching &False Discovery Assessment
(? days)
Collision cross section database
100 150 200 250 3000
200
400
600
800
1000
m/z
DTCCSN2 (Å2)
>600small molecules
Lipids
X. Zheng, et al., Chem. Sci. 2017, ASAP.
Primary metabolite trend lines
120 160 200 240
200
400
600
800
Amino AcidsNucleotidesSteroids
m/z
DTCCSN2 (Å2)
Protonated form
Primary metabolite trend lines
120 160 200 240
200
400
600
800
Amino AcidsNucleotidesSteroids
m/z
DTCCSN2 (Å2)
120 160 200 240
200
400
600
800
Amino Acids Fatty Acids Lipid Mediators Nucleotides Steroids Sugars
m/z
DTCCSN2 (Å2)
Protonated form Deprotonated form
Lipidomics
Sterols(Cholesterol)
Polyketides(2ndary Metabolites)
R1
Prenols(vitamins, quinones)
Fatty Acyls(Eicosanoids)
R1
n
Sphingolipids(Ceramides, SM)
Saccharolipids(DGDG, MGDG)
Glycerolipid(MG, DG, TG)
Glycerophospholipids(PC, PE, PG, PS, LP)
Lipid isomers1. Class isomers (PC and PE)
2. cis/trans double bond orientations
3. sn-1/sn-2/sn-3 fatty acyl positions
4. double bond locations
HO
O
HO
O
cis-Δ9 cis-Δ6
sn-2
sn-1 sn-3
PE(18:1/18:1) (cis-Δ9) PE(18:1/18:1) (trans-Δ9)
PE 36:2 < PC 33:2 but has the same elemental composition, C41H78NO8P
PC(14:0/16:0) < PC(16:0/14:0)
<
<
<
Ozonolysis or OzID
+
CriegeeAldehyde
Parent Lipid
Diagnostic IonsΔmass = 16 Da
Steve Blanksby
Ozonolysis on IMS instrument
ESI-OzID-IMS-MS of [PE(18:1/18:1)-H]-
No Ozone Ozone
[M-H]- [M-H]-
Both double bonds trans-Δ9
n-9
n-9, n-9
[M-H]-
[M-H]-
a,ac,a
c,c
ac
ESI-OzID-IMS-MS of PE(18:1/18:1)
[M-H]- [M+H]+
[M-H-110]- [M+H-110]+
cis, cis trans, trans
cis trans
cis, cis trans, trans
cis trans
cis, cis trans, trans
PC 34:1
LC-OzID-IMS-CID-MS in human plasma760.58
PC 34:1
[M-183+H]+
577.52
[M-256+H]+
504.34
599.50496.34[M+H]+
760.58782.57
[M-59+Na]+
723.50
[M-282+H]+
478.33[M+Na]+
PC (16:0/18:1)
NL 59
NL 183
NL 282
NL 2561
Nor
mal
ized
Inte
nsity
LC-OzID-IMS-CID-MS in human plasma760.58
0
600 650 7000.0
0.1N
orm
aliz
ed In
tens
ity
m/z
19.36min
Aldehyde650.44
Criegee666.44
PC 16:0/18:1 (n-9)
600 650 7000.0
0.1
Nor
mal
ized
Inte
nsity
m/z
19.2min
Criegee694.47
Aldehyde678.47
PC 16:0/18:1 (n-7)
[M-183+H]+
577.52
[M-256+H]+
504.34
599.50496.34[M+H]+
760.58782.57
[M-59+Na]+
723.50
[M-282+H]+
478.33[M+Na]+
PC (16:0/18:1)
O
O
OP
O-O
O
N+
O
O
NL 59
NL 183
NL 282
NL 2561
Nor
mal
ized
Inte
nsity
0
PC 34:1760.58
LC-OzID-IMS-CID-MS in human plasma
OzID @ RT 19.2 min OzID @ RT 19.36 min
600 650 7000.0
0.1N
orm
aliz
ed In
tens
ity
m/z
19.36min
Aldehyde650.44
Criegee666.44
PC 16:0/18:1 (n-9)
600 650 7000.0
0.1
Nor
mal
ized
Inte
nsity
m/z
19.2min
Criegee694.47
Aldehyde678.47
PC 16:0/18:1 (n-7)
19.2 19.60
1
Inte
nsity
Retention Time (minute)
760 678 694 650 666
PC 34:1
OzID @ RT 19.2 min OzID @ RT 19.36 min
[M-183+H]+
577.52
[M-256+H]+
504.34
599.50496.34[M+H]+
760.58782.57
[M-59+Na]+
723.50
[M-282+H]+
478.33[M+Na]+
PC (16:0/18:1)
NL 59
NL 183
NL 282
NL 2561
Nor
mal
ized
Inte
nsity
0
LC-OzID-IMS-CID-MS in human plasma
Summary
• Combining multiple separations and methods enables faster and better small molecule identifications as demonstrated with SPE-IMS-MS and LC-OzID-IMS-CID-MS analyses
LC IMS
CID
UVPD
MS
GC
SPE OzID
Acknowledgements• Agilent Technologies• National Institute of Environmental Health
Sciences of the NIH (R01ES022190)• NIH: General Medical Sciences Proteomics
Center at PNNL (2 P41 GM103493-11), National Institute of General Medical Sciences and National Cancer Institute
• PNNL Laboratory Directed Research and Development Program
• Environmental Molecular Sciences Laboratory
Noor Aly
Ion Mobility R&D Group